Search Results for 'Food and Drug Administration'

Medtronic the global leader in medical technology, today announced it is publicly sharing the design specifications for the Puritan Bennett™ 560 (PB 560) to enable participants across industries to evaluate options for rapid ventilator manufacturing to help doctors and patients dealing with COVID-19. This decision is consistent with the recent FDA Guidance and in accordance with the public health and medical response of governmental agencies globally.

Loughrea’s economic future will be boosted this morning (Thursday) when Tánaiste and Minister for Foreign Affairs and Trade, Simon Coveney, will officially open a new €10 million manufacturing facility at Chanelle Group in Loughrea.

One of the most common questions the team at Evergreen encounter on a daily basis is, 'What is the right supplement for me?' To help you in this confusing task they have outlined some simple tips to help you select the best food supplement.

A Ballybrit based medical device company has received some good news for its export business. ArraVasc designs, manufactures, and markets innovative devices for interventional clinicians across the world. In August the business received notification of FDA clearance, which will allow export sales to the USA. 

Galway-based medical device firm Crospon has this week announced that it has received clearance from the Food and Drug Administration (FDA) in the US for the first use of its EndoFLIP system in gastroenterology applications.

Galway-based medical device developer Crospon this week announced that its drug delivery technology platform has been spun out into a distinct company, Janisys, as a result of the continued development of the product prototype.

Galway-based medical device developer Crospon this week announced that its drug delivery technology platform has been spun out into a distinct company, Janisys, as a result of the continued development of the product prototype.

Local medical device developer Crospon has reason to celebrate on the double with the news that it has secured an additional €2 million in funding and that its flagship gastroenterology product has received clearance from the US Food and Drugs Administration.